Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1987 Mar;14(1):77–87.

Results of Heart Valve Replacement with the SORIN Prosthesis

Tiziano Colombo 1, Francesco Donatelli 1, Eugenio Quaini 1, Ettore Vitali 1, Alessandro Pellegrini 1
PMCID: PMC324697  PMID: 15227334

Abstract

From March 1977 to December 1981, 872 patients at our institution underwent valve replacement with a pyrolytic carbon tilting disc prosthesis manufactured in Italy by SORIN-Biomedica. To verify the performance characteristics of this prosthesis, we analyzed the intermediate-term results obtained over a cumulative total of 3,041 patient-years (pt-yr) of follow-up.

Three hundred sixty-nine patients underwent mitral valve replacement (MVR), 309 had aortic valve replacement (AVR), and 194 had both mitral and aortic (double) valve replacement (DVR). Expressed in actuarial terms (% [± standard error of the mean] free of adverse events at 5 years) and in linearized terms (% pt-yr), respectively, valve-related complications occurred at the following rates: Thromboembolism, 89.9 ± 1.9% and 2.1 ± 0.4% pt-yr (MVR); 92.1 ± 1.9% and 1.7 ± 0.4% (AVR); 90.5 ± 5.0% and 2.2 ± 0.6% (DVR). Anticoagulant-related hemorrhage, 95.2 ± 1.5% and 1.4 ± 0.3% (MVR); 95.9 ± 1.5% and 1.3 ± 0.3% (AVR); 96.0 ± 2.0% and 0.9 ± 0.4% (DVR). Prosthetic valve endocarditis, 99.0 ± 0.6% and 0.2 ± 0.1% (MVR); 97.4 ± 1.0% and 0.6 ± 0.2% (AVR); 94.5 ± 1.7% and 1.4 ± 0.4% (DVR). Reoperation, 92.6 ± 1.5% and 1.7 ± 0.3% (MVR); 89.4 ± 1.9% and 2.4 ± 0.4% (AVR); 82.3 ± 2.9% and 4.8 ± 0.8% (DVR). The total valve-related morbidity and mortality was 79.6 ± 2.6% and 4.9 ± 0.6% (MVR); 79.7 ± 2.6% and 5.1 ± 0.6% (AVR); 70.5 ± 4.0% and 7.7 ± 1.1% (DVR).

The 5-year actuarial survival rate without hospital mortality was 86.8 ± 2.0% (MVR), 91.0 ± 1.7% (AVR), and 78.8 ± 3.7% (DVR). The intermediate-term survival and complication rates showed the performance of the SORIN prosthesis to be quite satisfactory. (Texas Heart Institute Journal 1987; 14:77-87)

Keywords: Aortic valve replacement

Keywords: double valve replacement

Keywords: mitral valve replacement

Keywords: heart valve prosthesis

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnhorst D. A., Oxman H. A., Connolly D. C., Pluth J. R., Danielson G. K., Wallace R. B., McGoon D. C. Long-term follow-up of isolated replacement of the aortic or mitral valve with the Starr-Edwards prosthesis. Am J Cardiol. 1975 Feb;35(2):228–233. doi: 10.1016/0002-9149(75)90006-5. [DOI] [PubMed] [Google Scholar]
  2. Björk V. O., Henze A. Ten years' experience with the Björk-Shiley tilting disc valve. J Thorac Cardiovasc Surg. 1979 Sep;78(3):331–342. [PubMed] [Google Scholar]
  3. Björk V. O., Olin C. A hydrodynamic comparison between the new tilting disc aortic valve prosthesis (Björk-Shiley) and the corresponding prosthesis of Starr-Edwards, Kay-Shiley, Smeloff-Cutter and Wada-Cutter in the pulse duplicator. Scand J Thorac Cardiovasc Surg. 1970;4(1):31–36. doi: 10.3109/14017437009134237. [DOI] [PubMed] [Google Scholar]
  4. Björk V. O., Olin C. A hydrodynamic evaluation of the new tilting disc valve (Björk-Shiley) for mitral valve replacement. Scand J Thorac Cardiovasc Surg. 1970;4(1):37–43. doi: 10.3109/14017437009134238. [DOI] [PubMed] [Google Scholar]
  5. Colombi P., Donatelli F., Pomé G., Quaini E., Rossi C., Vitali E. Emergenze in chirurgia valvolare. G Ital Cardiol. 1983 Dec;13(12):357–362. [PubMed] [Google Scholar]
  6. Daenen W., Nevelsteen A., van Cauwelaert P., de Maesschalk E., Willems J., Stalpaert G. Nine years' experience with the Björk-Shiley prosthetic valve: early and late results of 932 valve replacements. Ann Thorac Surg. 1983 Jun;35(6):651–663. doi: 10.1016/s0003-4975(10)61079-x. [DOI] [PubMed] [Google Scholar]
  7. Ibarra F., Gutierrez A., Martinez F., Carreras L., Lopez C., Alonso-Lej F. Fracture of the outlet strut of a Björk-Shiley mitral prosthesis: emergency operation with survival. J Thorac Cardiovasc Surg. 1984 Feb;87(2):315–318. [PubMed] [Google Scholar]
  8. Jaumin P., Ponlot R., Schoevaerdts J. C., Brasseur L., Chalant C. H. Strut fracture of the Björk-Shiley aortic valve. J Thorac Cardiovasc Surg. 1984 Nov;88(5 Pt 1):787–788. [PubMed] [Google Scholar]
  9. Karp R. B., Cyrus R. J., Blackstone E. H., Kirklin J. W., Kouchoukos N. T., Pacifico A. D. The Björk-Shiley valve: intermediate-term follow-up. J Thorac Cardiovasc Surg. 1981 Apr;81(4):602–614. [PubMed] [Google Scholar]
  10. Lepley D., Jr, Flemma R. J., Mullen D. C., Singh H., Chakravarty S. Late evaluation of patients undergoing valve replacement with the Björk-Shiley prosthesis. Ann Thorac Surg. 1977 Aug;24(2):131–139. doi: 10.1016/s0003-4975(10)63721-6. [DOI] [PubMed] [Google Scholar]
  11. Macmanus Q., Grunkemeier G. L., Lambert L. E., Starr A. Non--cloth-covered caged-ball prostheses. The second decade. J Thorac Cardiovasc Surg. 1978 Dec;76(6):788–794. [PubMed] [Google Scholar]
  12. Macmanus Q., Grunkemeier G. L., Lambert L. E., Teply J. F., Harlan B. J., Starr A. Year of operation as a risk factor in the late results of valve replacement. J Thorac Cardiovasc Surg. 1980 Dec;80(6):834–841. [PubMed] [Google Scholar]
  13. McGoon D. C. The risk of thromboembolism following valvular operations: how does one know? J Thorac Cardiovasc Surg. 1984 Nov;88(5 Pt 1):782–786. [PubMed] [Google Scholar]
  14. Miller D. C., Oyer P. E., Mitchell R. S., Stinson E. B., Jamieson S. W., Baldwin J. C., Shumway N. E. Performance characteristics of the Starr-Edwards Model 1260 aortic valve prosthesis beyond ten years. J Thorac Cardiovasc Surg. 1984 Aug;88(2):193–207. [PubMed] [Google Scholar]
  15. Miller D. C., Oyer P. E., Stinson E. B., Reitz B. A., Jamieson S. W., Baumgartner W. A., Mitchell R. S., Shumway N. E. Ten to fifteen year reassessment of the performance characteristics of the Starr-Edwards Model 6120 mitral valve prosthesis. J Thorac Cardiovasc Surg. 1983 Jan;85(1):1–20. [PubMed] [Google Scholar]
  16. Pellegrini A., Peronace B., Marcazzan E., Rossi C. Long term results of isolated mitral and aortic valve replacement. A statistical evaluation. J Cardiovasc Surg (Torino) 1983 Sep-Oct;24(5):467–474. [PubMed] [Google Scholar]
  17. Rodewald G., Guntau J., Bantea C., Kalmar P., Krebber H. J., Rödiger W., Tilsner V. The risk of reoperation in acquired valvular heart disease. Thorac Cardiovasc Surg. 1980 Apr;28(2):77–88. doi: 10.1055/s-2007-1022056. [DOI] [PubMed] [Google Scholar]
  18. Sandza J. G., Jr, Clark R. E., Ferguson T. B., Connors J. P., Weldon C. S. Replacement of prosthetic heart valves. A fifteen-year experience. J Thorac Cardiovasc Surg. 1977 Dec;74(6):864–874. [PubMed] [Google Scholar]
  19. Teply J. F., Grunkemeier G. L., Sutherland H. D., Lambert L. E., Johnson V. A., Starr A. The ultimate prognosis after valve replacement: an assessment at twenty years. Ann Thorac Surg. 1981 Aug;32(2):111–119. doi: 10.1016/s0003-4975(10)61017-x. [DOI] [PubMed] [Google Scholar]
  20. Wideman F. E., Blackstone E. H., Kirklin J. W., Karp R. B., Kouchoukos N. T., Pacifico A. D. Hospital mortality of re-replacement of the aortic valve. Incremental risk factors. J Thorac Cardiovasc Surg. 1981 Nov;82(5):692–698. [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES